Newco Synchroneuron raises $6 million

Movement disorder newco Synchroneuron Inc. (Waltham, Mass.) raised $6 million in a series A round led by Morningside Technology Ventures. Synchroneuron's SYN-101, a modulator of the glutamate and NMDA...